Treatments that prevent recurrence of types of stroke and dementia caused by damage to small blood vessels in the brain have moved a step closer, following a small study.
The drugs – called cilostazol and isosorbide mononitrate – are already used to treat other conditions, such as heart disease and angina.
This is the first time they have been tested in the UK for the treatment of stroke or vascular dementia.
A study involving more than 50 stroke patients found that patients tolerated the drugs, with no serious side effects, even when the drugs were given in full dose or in combination with other medicines.
Experts say the findings pave the way for larger studies to check if the treatments can prevent brain damage and reduce risk of stroke and vascular dementia.
Damage to small blood vessels in the brain is responsible for around a quarter of strokes. It is also a common cause of memory problems and dementia.
Around 400,000 people in the UK are affected but there are no specific treatments. Currently the only way to reduce risk of the disease is by controlling blood pressure and cholesterol, stopping smoking and managing symptoms of diabetes.
Promising early signs
A team led by the Universities of Edinburgh and Nottingham recruited 57 patients who had experienced a stroke caused by damaged small blood vessels, known as a lacunar stroke.
Patients took the two medicines either individually or in combination for up to nine weeks, in addition to usual treatments aimed at preventing further strokes.
They completed health questionnaires and had regular blood pressure checks, blood tests and brain scans.
The findings suggest the drugs are safe for use in stroke patients, taken alone or in combination, at least in the short term.
There were also signs that the treatments helped improve blood vessel function in the arms and brain, and may improve thinking skills, but the researchers stress that further studies are needed to test this. A larger study, called LACI-2, is already underway.
The study, published in EClinicalMedicine, was funded primarily by the Alzheimer’s Society, with support from the UK Stroke Association, British Heart Foundation, the European Union, National Institutes of Health Research, and NHS Research Scotland.
We are delighted that the results of this trial show promise for treating a common cause of stroke and the commonest cause of vascular dementia, since currently there are no effective treatments. Further trials are underway.
Professor Joanna Wardlaw Centre for Clinical Brain Sciences
There hasn’t been a new drug for dementia for 15 years, so finding evidence that these cheap existing drugs could prevent dementia after a stroke would be a huge breakthrough. It’s promising to see that these two drugs are safe to use and we’ll be excited to see the results of the next stage of testing in a couple of years, which will show whether these drugs can be an effective treatment.
Dr James PickettHead of Research at Alzheimer’s Society
The Latest on: Stroke and vascular dementia
via Google News
The Latest on: Stroke and vascular dementia
- UC Davis School of Medicine and UTHealth receive NIH grant for dementia researchon October 7, 2020 at 4:22 pm
A team of brain scientists from UC Davis School of Medicine and The University of Texas Health Science Center at Houston has been awarded a six-year grant expected to total $53.6 million from the ...
- Catheter ablation linked to reduced risk of dementia in patients with atrial fibrillationon October 7, 2020 at 1:18 am
People with atrial fibrillation have a reduced risk of dementia if they undergo a procedure called catheter ablation to restore the normal rhythm of their heart, according to a new study published ...
- UC Davis School of Medicine and UTHealth get nearly $54 million for dementia researchon October 5, 2020 at 9:00 pm
A team of brain scientists from UC Davis School of Medicine and The University of Texas Health Science Center at Houston (UTHealth) has been awarded a six-year grant expected to total $53.6 million ...
- The Role of the Neurologic Examination in the Diagnosis and Categorization of Dementiaon October 3, 2020 at 5:00 pm
dementia with Lewy bodies, vascular dementia, and the frontotemporal lobar degenerations. The following are assessed or elicited: gait, frontal lobe signs, signs of parkinsonism, certain neuro ...
- Why I’m incensed my dad’s care home is shutting down – againon September 25, 2020 at 7:53 am
Just as lockdown measures were easing in care homes, some are closing their doors to visitors, leaving our elderly cut off from the world ...
- Insomnia, sleeping less than six hours may increase risk of cognitive impairmenton September 25, 2020 at 6:42 am
Middle-aged adults who report symptoms of insomnia and are sleeping less than six hours a night may be at increased risk of cognitive impairment, according to a study by Penn State College of Medicine ...
- Four of the most common early warning signs of vascular dementiaon September 23, 2020 at 11:09 pm
Vascular dementia is a type of dementia that’s caused by a reduced flow of blood to the brain. Signs of the condition may be similar to other types of dementia, but memory loss isn't usually the ...
- Medical myths: All about dementiaon September 21, 2020 at 2:27 pm
In contrast, brain cell death in vascular dementia occurs due to a lack of oxygen, which can result from a stroke, for instance. FTD, as another example, occurs when abnormal protein structures ...
- Dementia symptoms: Are you easily upset? It could be a sign of vascular dementiaon September 20, 2020 at 2:38 pm
Are you affected? An independent charity – Alzheimer's Support – noted how vascular dementia could also be brought on by a series of mini strokes (TIAs) or a stroke. One of the symptoms of ...
- High blood pressure and dementiaon August 15, 2020 at 12:21 am
Both type of strokes cause brain cell death that can lead to the development of stroke-related or post-stroke vascular dementia. Narrowing of the blood vessels especially deep inside the brain does ...
via Bing News